Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
431 studies found for:    United States, Vermont | University of Vermont
Show Display Options
Rank Status Study
21 Completed FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Condition: Type 2 Diabetes
Interventions: Drug: "GLIPULIN:" [insulin glargine, metformin, exenatide (GLP-1-agonist)];   Drug: Insulin glargine, metformin, prandial insulin
22 Active, not recruiting Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Adult T Acute Lymphoblastic Leukemia;   Childhood T Acute Lymphoblastic Leukemia;   Stage II Adult T-Cell Leukemia/Lymphoma;   Stage II Childhood Lymphoblastic Lymphoma;   Stage II Contiguous Adult Lymphoblastic Lymphoma;   Stage II Non-Contiguous Adult Lymphoblastic Lymphoma;   Stage III Adult Lymphoblastic Lymphoma;   Stage III Adult T-Cell Leukemia/Lymphoma;   Stage III Childhood Lymphoblastic Lymphoma;   Stage IV Adult Lymphoblastic Lymphoma;   Stage IV Adult T-Cell Leukemia/Lymphoma;   Stage IV Childhood Lymphoblastic Lymphoma;   Untreated Adult Acute Lymphoblastic Leukemia;   Untreated Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: Cytarabine;   Drug: Vincristine Sulfate;   Drug: Daunorubicin Hydrochloride;   Drug: Prednisone;   Drug: Pegaspargase;   Drug: Methotrexate;   Drug: Leucovorin Calcium;   Drug: Cyclophosphamide;   Drug: Mercaptopurine;   Radiation: Radiation Therapy;   Drug: Nelarabine;   Drug: Doxorubicin Hydrochloride;   Drug: Asparaginase;   Drug: Dexamethasone;   Drug: Thioguanine;   Other: Laboratory Biomarker Analysis
23 Completed Acupuncture Needling on Connective Tissue by Ultrasound
Condition: Healthy
Intervention:
24 Active, not recruiting A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
Condition: Cholera
Interventions: Biological: PXVX0200;   Biological: Placebo
25 Recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Urothelial Carcinoma;   Distal Urethral Carcinoma;   Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;   Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;   Proximal Urethral Carcinoma;   Recurrent Bladder Carcinoma;   Recurrent Prostate Carcinoma;   Recurrent Urethra Carcinoma;   Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;   Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;   Stage IV Bladder Cancer;   Stage IV Prostate Cancer;   Stage IV Urethral Cancer;   Ureter Carcinoma
Interventions: Drug: Gemcitabine Hydrochloride;   Drug: Cisplatin;   Other: Placebo;   Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis
26 Suspended Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Conditions: Adult Alveolar Soft-part Sarcoma;   Adult Angiosarcoma;   Adult Epithelioid Sarcoma;   Adult Extraskeletal Chondrosarcoma;   Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Liposarcoma;   Adult Neurofibrosarcoma;   Chondrosarcoma;   Endometrial Stromal Sarcoma;   Mast Cell Sarcoma;   Metastatic Adult Malignant Fibrous Histiocytoma of Bone;   Ovarian Carcinosarcoma;   Ovarian Sarcoma;   Recurrent Adult Malignant Fibrous Histiocytoma of Bone;   Recurrent Adult Soft Tissue Sarcoma;   Small Intestine Leiomyosarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Drug: alisertib;   Other: laboratory biomarker analysis
27 Active, not recruiting Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Condition: Childhood Acute Lymphoblastic Leukemia in Remission
Interventions: Behavioral: compliance monitoring;   Other: study of socioeconomic and demographic variables;   Drug: mercaptopurine tablet;   Drug: methotrexate
28 Terminated Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
Conditions: Adenocarcinoma of the Rectum;   Stage II Rectal Cancer;   Stage III Rectal Cancer
Interventions: Drug: oxaliplatin;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: bevacizumab;   Procedure: laboratory biomarker analysis
29 Unknown  The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy
Conditions: Breast Cancer;   Angiogenesis
Intervention: Drug: Aspirin
30 Active, not recruiting Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Conditions: Childhood Renal Cell Carcinoma;   Clear Cell Renal Cell Carcinoma;   Clear Cell Sarcoma of the Kidney;   Papillary Renal Cell Carcinoma;   Rhabdoid Tumor of the Kidney;   Stage I Renal Cell Cancer;   Stage I Wilms Tumor;   Stage II Renal Cell Cancer;   Stage II Wilms Tumor;   Stage III Renal Cell Cancer;   Stage III Wilms Tumor;   Stage IV Renal Cell Cancer;   Stage IV Wilms Tumor
Interventions: Drug: doxorubicin hydrochloride;   Drug: irinotecan hydrochloride;   Procedure: conventional surgery;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: carboplatin;   Biological: dactinomycin;   Drug: vincristine sulfate;   Radiation: radiation therapy;   Other: laboratory biomarker analysis
31 Recruiting Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: B-cell Adult Acute Lymphoblastic Leukemia;   B-cell Childhood Acute Lymphoblastic Leukemia;   Cognitive/Functional Effects;   Neurotoxicity;   Pain;   Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia;   Therapy-related Toxicity;   Untreated Adult Acute Lymphoblastic Leukemia;   Untreated Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: clofarabine;   Drug: doxorubicin hydrochloride;   Drug: hydrocortisone sodium succinate;   Radiation: selective external radiation therapy;   Drug: cytarabine;   Drug: vincristine sulfate;   Drug: dexamethasone;   Drug: prednisone;   Drug: pegaspargase;   Drug: methotrexate;   Drug: cyclophosphamide;   Drug: mercaptopurine tablet;   Drug: leucovorin calcium;   Drug: thioguanine;   Drug: etoposide
32 Completed Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Atrasentan
33 Completed The Labor and Delivery Teamwork Intervention Trial
Condition: Adverse Maternal and Neonatal Outcomes
Intervention: Behavioral: Labor and Delivery Team Coordination Course
34 Completed Behavioral Economics of Human Drug Self-Administration
Condition: Drug Dependence
Interventions: Drug: nicotine;   Drug: alcohol
35 Recruiting Study of Kidney Tumors in Young Patients
Conditions: Clear Cell Sarcoma of the Kidney;   Congenital Mesoblastic Nephroma;   Diffuse Hyperplastic Perilobar Nephroblastomatosis;   Rhabdoid Tumor of the Kidney;   Stage I Renal Cell Cancer;   Stage I Wilms Tumor;   Stage II Renal Cell Cancer;   Stage II Wilms Tumor;   Stage III Renal Cell Cancer;   Stage III Wilms Tumor;   Stage IV Renal Cell Cancer;   Stage IV Wilms Tumor;   Stage V Wilms Tumor
Interventions: Other: laboratory biomarker analysis;   Other: cytology specimen collection procedure
36 Recruiting Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma
Conditions: Untreated Childhood Medulloblastoma;   Untreated Childhood Pineoblastoma;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
Interventions: Radiation: radiation therapy;   Drug: vincristine sulfate;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Biological: filgrastim;   Drug: isotretinoin;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
37 Recruiting Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: B-cell Adult Acute Lymphoblastic Leukemia;   B-cell Childhood Acute Lymphoblastic Leukemia;   T-cell Adult Acute Lymphoblastic Leukemia;   T-cell Childhood Acute Lymphoblastic Leukemia;   Untreated Adult Acute Lymphoblastic Leukemia;   Untreated Childhood Acute Lymphoblastic Leukemia
Interventions: Other: laboratory biomarker analysis;   Other: cytology specimen collection procedure
38 Completed The Use of the Internet to Facilitate Weight Loss and Maintenance.
Condition: Obesity
Intervention: Behavioral: Behavioral weight loss
39 Recruiting Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Condition: Huntington's Disease
Intervention:
40 Recruiting Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
Conditions: Diffuse Hyperplastic Perilobar Nephroblastomatosis;   Stage I Wilms Tumor;   Stage II Wilms Tumor;   Stage III Wilms Tumor;   Stage IV Wilms Tumor;   Stage V Wilms Tumor
Interventions: Drug: doxorubicin hydrochloride;   Procedure: therapeutic conventional surgery;   Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: carboplatin;   Drug: etoposide phosphate;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: neoadjuvant therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years